Tenants
Biotechnology company researching cell preservation technology for drug evaluation and regenerative medicine. Abcellute's 'Human Tissue Bank' supplies non-transplantable human tissue for use in bio-medical research programmes
ABS Laboratories is a GLP accredited contract research organisation. Our aim is to provide a high quality, regulatory compliant analytical and bioanalytical service to the drug development industry, heath monitoring authorities and other similar organisations. We routinely apply existing analytical methods or develop bespoke bioanalytical methods in partnership with our sponsors to satisfy their business requirements.
Antisoma is a biotechnology company specialising in the development of novel drugs for the treatment of cancer and has a diverse portfolio of drugs in development including ASA404, a leading Vascular Disrupting Agent (tVDA), that will shortly enter phase III in lung cancer. Antisoma last year licensed ASA404 to Novartis in a deal with a milestone value of up to $890 million. Another drug, AS1411, is in phase II, and the company has two other drugs in clinical development as well as pre-clinical-stage programmes.
Argenta Discovery is focused on the discovery and development of novel therapies for chronic respiratory disease. Argenta intends to advance its programmes to Phase IIa 'proof of concept' clinical trial and then collaborate with pharmaceutical partners to complete development and commercialisation. Argenta's contract research division provides fully integrated drug discovery services and has experience across most drug targets and disease areas.
Registered Office.
Ascension Orthopedics was founded in Austin, Texas in 1996. The first product of Ascension was an innovative pyrolytic carbon total joint replacement for the MCP joint of the hand. The company has since increased its joint replacement product line to include implants for the shoulder, elbow, wrist, fingers and toes. Ascension’s mission is to develop state of-the-art orthopedic products for upper and lower extremities to help patients suffering from pain and dysfunction. Ascension Orthopedics sells product in the United States and in more than 23 countries worldwide and is dedicated to Transforming Extremities.
Azopharma specializes in drug development support for the pharmaceutical industry. Experts at formulations, custom synthesis, isolation/purification, elucidation, characterization, method development and validation, clinical supplies for Phase I.
BABS Biomarker Services
Recently established consortium providing 'open access' biomarker consultancy and analytical services.
Canary Wharf Life Sciences Ltd
Registered Office.
Cresset BioMolecular Discovery has developed a revolutionary new way of describing molecules in silico. Our unique approach describes the electron field and surface properties of a molecule. It provides a 'protein's eye view' of the ligand, allowing structurally diverse compounds with similar biological activity to be identified, facilitating rapid hit-finding and lead-switching.
Cyclofluidic is an emerging technology company founded by UCB and Pfizer and supported by the UK Technology Strategy Board (TSB) with the goal of improving the efficiency of drug discovery through the integration of chemistry and biology. We are developing an integrated microfluidic platform combining both chemical synthesis and biological assay to rapidly deliver high quality molecules and data to feed the drug development pipeline. With a highly experienced team of professionals combining both drug discovery and technology development experience we are uniquely placed to exploit this and other discovery technology opportunities.
Creates and commercializes best-in-class products to analyze and process living cells more efficiently and with far greater accuracy than any technology in use today. Cyntellect's products are currently used to advance the state of life science research, biopharmaceutical production, stem cell research and drug discovery.
Invented by Essen in 2002, IonWorksTM was the first high-throughput (HT) electrophysiology platform for mammalian cells on the market; consequently, we have been doing HT electrophysiology in our labs for many years. Consistent with our philosophy to develop turn-key assays, we also have developed and maintained the expertise in assay development and cell preparation to make high-throughput electrophysiology work.
Heptares Therapeutics Ltd is a drug discovery company focused on the design and development of novel drugs based on G-protein-coupled receptors (GPCRs), the largest family of druggable targets.
ICE provides specialist and advanced IT consultancy services to companies ranging from SMEs to large Blue Chips. Current clients include both private and public sector organisations.
Registered Office. Assists the medical device industry by managing their international regulatory compliance activities.
Mirage Health Group is a leading provider of Medical and Dental Products. Its Propulse range of Ear Care Equipment, including the Propulse Electronic Ear Irrigator is recognised as the first choice of clinicians in the UK and internationally. Mirage Dental manufacturers the Hydrofloss Kitty WaterJet Oral Irrigator and the FLIX range of interdental sticks, helping to improve personal oral care around the world.
Momentum Bioscience
Momentum Bioscience Ltd is developing LiMA, a platform for detecting viable bacteria and fungi in clinical specimens. LiMA combines the advantages of molecular detection (rapid, detects non-culturable organisms) with those of conventional blood culture (only detects viable organisms; detects all organisms; allows antimicrobial sensitivity tests). With LiMA a physician will be able to diagnose an infection and know which antibiotic to prescribe within 24 hours of taking a blood sample. LiMA can also be used for joint fluids and other sterile clinical samples, environmental monitoring and other applications.
Novacta develops novel drugs for infectious diseases, to provide sustainable solutions to drug resistance and disease recurrence. Novacta targets infections caused by Clostridium difficile and MRSA and skin infections such as impetigo and acne. Novacta's pipeline includes a C. difficile drug candidate in preclinical development. Novacta also has established alliances with pharmaceutical and chemical companies to accelerate product discovery or improve process economics.
Presearch was founded in 1991 with the aim of providing elegant solutions to emerging issues in HPLC and related techniques. Whilst we still retain this as one of our key activities, we have expanded into other areas as clear customer needs and technology developments have become apparent.
Provides a range of outsourced services to the pharmaceutical sector. Clinical Trials Assembly Licence holder.
Sivaden Ltd provides support and advice for young biotech companies. Our services include business planning, deal structuring and negotiation, market assessments, product and technology valuation and partner identification. We also provide non-executive directors and interim management to help companies develop. Our clients include universities, new start-ups and young companies in all areas of biotechnology in the UK, Europe and US.
Registered Office. Late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of allogeneic hematopoietic cell transplantation.
Patent attorneys specialising in biotech and chemical technology particularly in the context of the pharmaceutical field.
The Tarilian Group specialise in the Medical Technology arena on a global platform. Our expertise crosses all levels of the product development lifecycle: from concept through to registration. Tarilian Consulting Ltd provides a bespoke consulting service drawing upon our teams of experts to add value to the projects of our clients. The Group also has a micro-engineering company focusing mainly in the cardiovascular area.
Temag Pharma Limited is a manufacturer and supplier of made to order unlicensed medicinal products to Hospitals, Pharmacies and Dispensing Doctors. We are a registered pharmaceutical laboratory and specialise in the extemporaneous preparation and dispensing of unlicensed medicines otherwise known as ‘Specials’. All activities are carried out and supervised under the guidance of specialised pharmacists.